Friday, 17 September 2021
  2 Replies
  2.2K Visits

The WHO’s Department of Immunization, Vaccines and Biologicals (IVB) and WHO Health Emergency programme (WHE) are partnering with Project ECHO of the University of New Mexico (UNM), UNICEF, and TechNet-21 to host a series of 15 sessions that align with countries’ immediate and medium-term needs.

Webinar series topic: WHO Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines 

The objectives of this webinar series are to optimize the use of existing resources and technical assistance through sharing of guidance, tools, resources, learnings, and best practices to support costing, budgeting, and financing of C19 immunization programs by:
  1. providing technical assistance on the use of C19 tools, guidance, resources, and trainings on costing, budgeting and financing, including the use of the updated CVIC tool version 2.2;
  2. sharing best practices in a community of practice on key challenges, benefits, and use of costing and budgeting tools such as the CVIC 2.2 as well as strategies to maintain routine immunization services


Next session Pfizer COVID-19 Vaccine: Planning and Implementation 

Vaccination is one of the effective interventions to prevent high morbidity and mortality due to COVID-19. Among the COVID-19 vaccines approved under Emergency Use Listing (EUL), only Pfizer-BioNTech COVID-19 vaccine requires storage at ultra-low temperature. Only very few countries have experience managing vaccine in this  storage condition. This session aims to guide countries in establishing ultra-cold chain system with appropriate equipment and support health workers in implementing delivery strategies to ensure populations at risk are reached and administered with potent Pfizer-BioNTech COVID-19 vaccine.

Interpretation into French and Spanish will be available 

When: Wednesday 22 September 12:00 CET

Registration link: 

2 years ago

The recording of the webinar session: Pfizer-BioNTech COVID-19 Vaccine: Planning and Implementation is now available on Youtube in:

- English:

- French:

- and Spanish:


For presentations, recordings and Q&A from the previous sessions, please visit our dedicated page:

2 years ago

Answers to all questions asked during the webinar session Pfizer-BioNTech COVID-19 Vaccine: Planning and Implementation have now been provided by the session presenters. The full Q&A has been consolidated into a single document that can be found here:,-budgeting,-financing-and-delivery-of-covid-19-vaccines---q&a-for-session-08:-pfizer-biontech-covid-19-vaccine:-planning-and-implementation

These are the questions that have been answered:

  • What are the most common vaccination strategies in Africa? And what are the hardest ones to implement? 

  • What is the minimum shelf life of vaccine required for countries in order to achieve a smooth uptake of vaccines, as we are getting information that a huge amount of vaccines will expire soon, by the end of September 2021? 

  • Most of the COVID-19 vaccines have a short shelf life by the time it is received by the country. What is the lowest shelf life that a country can use, understanding it will vary from country to country, and is based on the maturity level of their vaccine delivery system? 

  • Which kind of training is to be conducted every week? Is this formal training or update on key information? 

  • Which strategy is preferable for Pfizer-BioNTech vaccine rollout in low CCE infrastructure set up? 

  • What is the way forward on routinizing COVID-19 vaccination with the RI? 

  • What is the target polulation eligible to get the Pfizer-BioNTech vaccine in final approval for use? Can the Pfizer-BioNTech vaccine be used as a 2nd dose or 3rd dose, mixing with 1st dose with another vaccine? 

  • Is it adequate for a country to receive the vaccine with a 2 months shelf life? 

  • When you take vaccine from -80°C to -20°C and then back to -80°C, can you take it back to -20°C again? Does the first transfer change the expiry date? 

  • Is it compulsory to use Arktek devices? What if a country doesnt have Arktek devices but have Cold boxes? 

  • Is 700L the highest UCC freezer capacity? 

  • Are countries really able to choose whether the equipment has dual temperature or is this decided at global level for countries? 

  • Can you please share official guidelines regarding the extension of shelf-life of the Pfizer-BioNTech vaccine from 6 months to 9 months? Can this be applied to already manufactured vials too? Or is it only for the vaccines produced after some specific date? 

  • What is the difference between frozen water packs and conditioned frozen water packs? 

  • Mapping of dry ice production facility is critical if thermal shipper is used for a long period. How many days can a thermal shipper be used by replacing dry ice? 

  • Page :
  • 1
There are no replies made for this post yet.